CASP1 and metabolic dysfunction-associated steatotic liver disease: The aforementioned investigations indicate that caspase-1/11 exerts a crucial influence on the modulation of both hepatic lipid composition and gut microbiota composition, implicating its involvement in the development of NAFLD.